Outset Medical
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Outset Medical sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Outset Medical: 4 sponsored US clinical trials, none currently recruiting.
Outset Medical sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. The most-studied condition in this pipeline is End Stage Renal Disease on Dialysis, with 1 trials.
Upper-quartile sponsor footprint
Outset Medical sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
EXtension of Tablo TrEatmeNt Duration Registry
NCT04912050
Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study
NCT04912024
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
NCT05947708
The EvAluation of TaBlo In-CLinic and In-HOme
NCT02460263
Therapeutic Areas
How the Outset Medical archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: End Stage Renal Disease on Dialysis (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Outset Medical: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Outset Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Outset Medical page
4 registered trials is a research-attention snapshot, not an endorsement of Outset Medical or any single study.
- None of Outset Medical's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- End Stage Renal Disease on Dialysis is the condition Outset Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See End Stage Renal Disease on Dialysis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Outset Medical pipeline card: 4 registered trials from official public datasets.Report a data error.